LIVING WITH SQUAMOUS CELL SKIN CANCER:
DEALING WITH THE SIDE EFFECTS OF TREATMENT
All treatments can have side effects. It’s important to know what side effects to expect from squamous cell skin cancer therapies and how to work with your healthcare team to manage them.
Surgery
Surgery carries both short- and long-term risks. This section will not cover short-term side effects of surgery such as bleeding, adverse reactions to medications, or difficulty closing the wound, because these are associated with the immediate surgical event, and your doctor will likely give you information after surgery addressing these issues.
Surgery can affect different body systems. Sensory nerve damage can occur with surgery, leading to localised numbness, a sensation of pins and needles, or burning or severe pain. Motor nerve damage can also occur, resulting in weakness or paralysis. In general, if the involved area is small, nerve damage may improve or resolve in approximately 12 months. However, sometimes the neurologic symptoms remain. Another intermediate- to longer-term complication that can occur after surgery is wound infection. The wound can also break down, or healing can be delayed. It’s important to keep your follow-up appointments with your surgery team and report any side effects immediately. Team members can offer strategies to address some of these complications.
Lymphoedema (lim·fuh·dee·muh) is an accumulation of lymph in the soft tissue (swelling) caused by the damage/removal of lymph nodes/lymphatic channels. It can occur either short term or long term for patients with squamous cell skin cancer who have had more extensive surgery. A lymphoedema therapist can help with skin care, massage, bandaging, exercises, or a compression garment. This treatment is called complex decongestive therapy (CDT). For more about specific lymphoedema management, see Lymphoedema treatment – lymphatic drainage massage, exercise | Macmillan Cancer Support
One of the biggest challenges with advanced squamous cell skin cancer (beyond the threat of poor overall outcomes) is the potential for unsightly cosmetic results. This can include loss or darkening of skin colour, suture marks, or excessive scarring. When the squamous cell skin cancer is highly invasive, the degree of disfigurement can be substantial. Having a good reconstruction plan and follow-up with your surgeon is important. In one study, squamous cell skin cancer patients reported reduced quality of life one month after surgery because of pain, functional challenges, and cosmetic challenges. Importantly, this response improved over the course of the year after surgery. However, for patients with disfigurement, an aggressive plan for reconstruction and emotional support and counselling can be very important.
Effects of Radiation Therapy
Side effects of radiation are usually restricted to the area that has been radiated and can include:
- Irritation of skin, ranging from redness to blistering and peeling
- Changes in skin colour
- Loss of hair in the area being treated
- A long-term increase in new skin cancers in the area treated with radiation
- Damage to the salivary glands and teeth when treating cancers near the mouth
- Fatigue, taste changes, difficulty swallowing, and a less active thyroid gland (usually associated with radiation to the head and neck)
It’s important to talk with your radiology team about strategies to deal with these side effects. Some self-care approaches you can take include:
- Getting plenty of rest and establishing a good sleep routine
- Eating a balanced, nutrient-rich diet
- Taking care of the skin in the area that has received radiation. Be particularly careful to protect it from the sun, heat, and cold
- Avoiding irritating the skin by wearing tight or restrictive clothing
Effects of Immunotherapy
Immune checkpoint inhibitors rev up the immune system and cause a range of side effects. These can be considered autoimmune in nature. The figure below shows the body systems that can be involved.
Concerning side effects associated with immunotherapy are lung, liver, skin, neurologic, cardiac, and ocular problems; gastrointestinal inflammation; and hormonal problems affecting glands like the adrenal, pituitary, thyroid glands, and the pancreas. Serious side effects occurred in approximately one quarter or less patients in immunotherapy clinical trials.
With immunotherapy, reducing the dosage is not generally recommended. The management of these side effects typically involves stopping immunotherapy and then managing the side effect. In many of the moderate cases, corticosteroids are used to quiet the immune system, after which immunotherapy can be restarted. But in severe cases, the drug may need to be discontinued.
The following educational videos, courtesy of the IO Essentials Initiative, feature oncology experts discussing various side effects associated with immunotherapy.
In this video, Eric Whitman, MD, FACS, of the Atlantic Health System, provides tips for patients about the proper use of corticosteroids for immune-related adverse events.
In this video, Jessica Mitchell, APRN, CNP, MPH, of the Mayo Clinic, discusses the diarrhoea and colitis (inflammation of the colon) that can occur with immune checkpoint inhibitors.
In this video, Eric D. Whitman, MD, FACS, comments on the common symptom of fatigue and how that will be worked up in the patient receiving immune checkpoint inhibitors.
In this video, Laura J. Zitella, MS, RN, ACNP-BC, AOCN®, of the University of California, San Francisco, discusses hypothyroidism and what patients receiving immune checkpoint inhibitors should be on the lookout for.
In this video, Laura J. Zitella, MS, RN, ACNP-BC, AOCN®, of the University of California, San Francisco, discusses liver problems (hepatitis) in patients receiving immune checkpoint inhibitor therapy.
In this video, Brianna Hoffner, MSN, AOCNP, RN, of the University of Colorado, discusses steps patients can take to deal with the skin toxicities associated with use of immune checkpoint inhibitors.
In this video, Marianne J. Davies, DNP, MSN, RN, APRN, CNS-BC, ACNP-BC, AOCNP, of Yale University, discusses adrenal insufficiency in patients receiving immune checkpoint inhibitors and what patients should be on the lookout for.
© 2024 SkinCancerCare, Terranova Medica, LLC, and Integrita Foundation, LLC. All rights reserved.